ARTICLE SUMMARY:
The veteran medtech innovator sees Avail Medsystems' technology as a prime example of where device development is heading, both in robotics and digital surgery and beyond.
Fred Moll has a day job. The robotics innovator and founder of Intuitive Surgical, Hansen Medical, and Auris Health, is currently the Chief Development Officer of Johnson & Johnson. He assumed that position when J&J paid $3.4 billion (with $2.35 billion in additional milestones) to acquire Auris in February of 2019. In that deal, Auris essentially sold J&J two robotic systems: one, Monarch for endoscopy, which has been completed, and a different kind of system that is still being developed, and Moll wants to “stick around long enough to make sure that is done correctly.” So, with those and other future projects on his plate, why is he devoting so much time to Avail Medsystems Inc.?
